Skip to main content
Log in

The Protection of Enzyme Activity for the Preparation of Humanized Polymerized Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase

  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

This work finds suitable enzyme activity protectants to improve the recovery rate of enzyme activity in the preparation of human polymerized hemoglobin-superoxide dismutase-catalase-carbonic anhydrase (PolyHb-SOD-CAT-CA), including trehalose, sucrose, glucose, hydroxypropyl-β-cyclodextrin, and mannitol.Different types and concentrations of enzyme activity protective agents were added during polymerization to compare their protective ability to enzyme activity and the effect on the properties of hemoglobin. The study found that compared with trehalose, the protective effect of sucrose on CA enzyme activity is non-significant to that on hemoglobin, the recovery rate of SOD, and CAT enzyme activity has significant increased. Glucose, hydroxypropyl-β-cyclodextrin, and mannitol are unsuitable for the added enzyme activity protective agent of PolyHb-SOD-CAT-CA.The protective effect of sucrose on CA was non-significant with trehalose. The protective effect of sucrose on SOD and CAT enzyme activity was higher than trehalose, and the protective effect reached the maximum when the concentration reached 1.5%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. Chang, T.M.S., Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 2010, vol. 2, no. 4, pp. 418–430.

    CAS  PubMed  Google Scholar 

  2. Hughes, G.S., Jr., Antal, E.J., Locker, P.K., Fran-com, S.F., Adams, W.J., and Jacobs, E.E., Jr., Physiology, and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans, Crit. Care Med., 1996, vol. 24, no. 5, p. 756.

    Article  PubMed  Google Scholar 

  3. Chang, T.M.S., D’Agnillo, F., Yu, W.P., and Razack, S., Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation, Adv. Drug Delivery Rev., 2000, vol. 40, no. 3, pp. 213–218.

    Article  CAS  Google Scholar 

  4. Chang, T.M.S., Hemoglobin-based red blood cell substitutes, J. Artificial Organs, 2004, vol. 28, no. 9, pp. 789–794.

    Article  CAS  Google Scholar 

  5. Chang, T.M.S., Pharmaceutical and therapeutic applications of artificial cells including microencapsulation, Eur. J. Pharm. Biopharm., 1998, vol. 45, no. 1, pp. 3–8.

    Article  CAS  PubMed  Google Scholar 

  6. Natanson, C., Kern, S.J., Lurie, P., Banks, S.M., and Wolfe, S.M., Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death, JAMA, 2008, vol. 299, no. 19, p. 2304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. FDA, Blood Guidances—Draft Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes, 2004.

  8. Pusateri, A.E., Glassberg, E., and Weiskopf, R.B., Reassessment of the need for an oxygen carrier for the treatment of traumatic hemorrhage when blood is not an option, Shock, 2019, vol. 52, pp. 55–59.

    Article  CAS  PubMed  Google Scholar 

  9. Alayash, A.I., Hemoglobin-based blood substitutes and the treatment of sickle cell disease: more harm than help?, Biomolecules, 2017, vol. 7, p. 2.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Matsuoka, T., Determination of methemoglobin and carboxyhemoglobin in blood by rapid colorimetry, Biol. Pharm. Bull., 1997, vol. 20, no. 11, pp. 1208–1211.

    Article  CAS  PubMed  Google Scholar 

  11. Chang, T.M.S., Lister, C., Varma, N., and Varma, R., Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin, and conjugated hemoglobin using different immunization schedules, Biomater., Artif. Cells, Immobilization Biotechnol., 1992, vol. 20, nos. 2–4, pp. 611–618.

    Article  CAS  PubMed  Google Scholar 

  12. Wu, M., Feng, K., Li, Q., Ma, H., Zhu, H., Xie, Y., et al., Glutaraldehyde-polymerized hemoglobin and tempol (PolyHb-tempol) has superoxide dismutase activity that can attenuate oxidative stress on endothelial cells induced by superoxide anion, Artif. Cells, Nanomed., Biotechnol., 2017, vol. 46, no. 1, pp. 47–55.

    Article  PubMed  Google Scholar 

  13. Nadine, V. and Bae, Y.H., Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress, Int. J. Biol. Macromol., 2010, vol. 47, no. 5, pp. 603–613.

    Article  Google Scholar 

  14. Chang, T.M.S., Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia–reperfusion, Artif. Cells, Blood Substitutes, Biotechnol., 2002, vol. 30, no. 1, pp. 23–37.

    Google Scholar 

  15. Bian, Y., Rong, Z., and Chang, T.M.S., Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant, Artif. Cells, Blood Substitutes, Biotechnol., 2011, vol. 40, nos. 1–2, pp. 28–37.

    Google Scholar 

  16. Bian, Y. and Chang, T.M.S., A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume, Artif. Cells, Nanomed., Biotechnol., 2014, vol. 43, no. 1, pp. 1–9.

    Article  PubMed  Google Scholar 

  17. Guo, C., Gynn, M., and Chang, T.M.S., Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase, Artif. Cells, Nanomed., Biotechnol., 2015, vol. 43, no. 3, pp. 157–162.

    Article  PubMed  Google Scholar 

  18. Hottiger, T., Virgilio, C., Hall, M.N., Boller, T., and Wiemken, A., The role of trehalose synthesis for the acquisition of thermotolerance in yeast. II. Physiological concentrations of trehalose increase the thermal stability of proteins in vitro, Eur. J. Biochem., 1994, vol. 219, nos. 1–2, pp. 187–193.

    Article  CAS  PubMed  Google Scholar 

  19. Sola-Penna, M. and Meyer-Fernandes, J.R., Stabilization against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars?, Arch. Biochem. Biophys., 1998, vol. 360, no. 1, pp. 10–14.

    Article  CAS  PubMed  Google Scholar 

  20. Liao, Y.H., Brown, M.B., Quader, A., and Martin, G.P., Protective mechanism of stabilizing excipients against dehydration in the freeze-drying of proteins, Pharm. Res., 2002, vol. 19, no. 12, pp. 1854–1861.

  21. Tomoda, A., Takizawa, T., and Yoneyama, Y., Mechanism of autoxidation of hemoglobin Kempsey (β99 ASP → ASN), Hemoglobin, 1984, vol. 8, no. 2, pp. 137–149.

    Article  Google Scholar 

Download references

Funding

The authors are grateful to the financial support from the Science and Technology Platform Talents Project of Guizhou Province (Qiankehe Platform Talents (2018) 5772-024).

Author information

Authors and Affiliations

Authors

Contributions

Yaoxi Wang: Data curation, Investigation, Wanjun Wang: Methodology, Lili Zhang: Writing, Gang Chen: Conceptualization.

Corresponding author

Correspondence to Gang Chen.

Ethics declarations

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

All studies were conducted in accordance with the principles of biomedical ethics as outlined in the 1964 Declaration of Helsinki and its later amendments. They were also approved by the Ethics Committee of Zunyi Medical University (code: 20220602Z15, date: June 3, 2022). Each participant in the study provided a voluntary written informed consent after receiving an explanation of the potential risks and benefits, as well as the nature of the upcoming study.

Additional information

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Wang, W., Zhang, L. et al. The Protection of Enzyme Activity for the Preparation of Humanized Polymerized Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase. Dokl Biochem Biophys (2024). https://doi.org/10.1134/S1607672923600483

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1134/S1607672923600483

Keywords:

Navigation